{"title":"CARD9缺乏症并发念珠菌和胞内分枝杆菌中枢神经系统感染:一例免疫学观察","authors":"Tomonari Shigemura, Haruo Nagumo, Norimoto Koabayashi, Kazunaga Agematsu, Takamasa Saito, Takashi Kurata, Shiho Asaka, Tomomi Yamaguchi, Tomoki Kosho, Yozo Nakazawa","doi":"10.1093/cei/uxag024","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Caspase recruitment domain-containing protein 9 (CARD9) deficiency is classically characterized by chronic mucocutaneous candidiasis (CMC) and invasive Candida infections, including central nervous system (CNS) disease. Susceptibility to mycobacterial infection has not been considered a defining feature of CARD9 deficiency.</p><p><strong>Methods: </strong>We describe a patient with a typical clinical phenotype of CARD9 deficiency associated with compound heterozygous variants in CARD9, initially presenting with CMC and later manifesting CNS candidiasis, complicated by a concurrent CNS infection caused by Mycobacterium intracellulare. This unexpected finding prompted detailed immunological analyses to determine whether the mycobacterial infection represented a coincidental event or reflected an underlying susceptibility.</p><p><strong>Results: </strong>Immunological studies demonstrated preserved neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent reactive oxygen species production, whereas bactericidal/permeability-increasing protein (BPI) was uniquely and markedly reduced among neutrophil antimicrobial proteins. In parallel, monocyte-derived dendritic cells exhibited impaired tumor necrosis factor-α (TNF-α) production in response to mycobacterial stimulation, suggesting impaired cytokine responses downstream of CARD9.</p><p><strong>Conclusion: </strong>These findings suggest that impaired dendritic cell cytokine responses to mycobacteria, together with markedly reduced neutrophil BPI content, may have contributed to the development of M. intracellulare infection in this patient. Our study highlights a potential mechanism underlying susceptibility to mycobacterial infection in CARD9 deficiency.</p>","PeriodicalId":10268,"journal":{"name":"Clinical and experimental immunology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Concurrent central nervous system infection with Candida and Mycobacterium intracellulare in CARD9 deficiency: immunological insights from a single case.\",\"authors\":\"Tomonari Shigemura, Haruo Nagumo, Norimoto Koabayashi, Kazunaga Agematsu, Takamasa Saito, Takashi Kurata, Shiho Asaka, Tomomi Yamaguchi, Tomoki Kosho, Yozo Nakazawa\",\"doi\":\"10.1093/cei/uxag024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Caspase recruitment domain-containing protein 9 (CARD9) deficiency is classically characterized by chronic mucocutaneous candidiasis (CMC) and invasive Candida infections, including central nervous system (CNS) disease. Susceptibility to mycobacterial infection has not been considered a defining feature of CARD9 deficiency.</p><p><strong>Methods: </strong>We describe a patient with a typical clinical phenotype of CARD9 deficiency associated with compound heterozygous variants in CARD9, initially presenting with CMC and later manifesting CNS candidiasis, complicated by a concurrent CNS infection caused by Mycobacterium intracellulare. This unexpected finding prompted detailed immunological analyses to determine whether the mycobacterial infection represented a coincidental event or reflected an underlying susceptibility.</p><p><strong>Results: </strong>Immunological studies demonstrated preserved neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent reactive oxygen species production, whereas bactericidal/permeability-increasing protein (BPI) was uniquely and markedly reduced among neutrophil antimicrobial proteins. In parallel, monocyte-derived dendritic cells exhibited impaired tumor necrosis factor-α (TNF-α) production in response to mycobacterial stimulation, suggesting impaired cytokine responses downstream of CARD9.</p><p><strong>Conclusion: </strong>These findings suggest that impaired dendritic cell cytokine responses to mycobacteria, together with markedly reduced neutrophil BPI content, may have contributed to the development of M. intracellulare infection in this patient. Our study highlights a potential mechanism underlying susceptibility to mycobacterial infection in CARD9 deficiency.</p>\",\"PeriodicalId\":10268,\"journal\":{\"name\":\"Clinical and experimental immunology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2026-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and experimental immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/cei/uxag024\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cei/uxag024","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Concurrent central nervous system infection with Candida and Mycobacterium intracellulare in CARD9 deficiency: immunological insights from a single case.
Introduction: Caspase recruitment domain-containing protein 9 (CARD9) deficiency is classically characterized by chronic mucocutaneous candidiasis (CMC) and invasive Candida infections, including central nervous system (CNS) disease. Susceptibility to mycobacterial infection has not been considered a defining feature of CARD9 deficiency.
Methods: We describe a patient with a typical clinical phenotype of CARD9 deficiency associated with compound heterozygous variants in CARD9, initially presenting with CMC and later manifesting CNS candidiasis, complicated by a concurrent CNS infection caused by Mycobacterium intracellulare. This unexpected finding prompted detailed immunological analyses to determine whether the mycobacterial infection represented a coincidental event or reflected an underlying susceptibility.
Results: Immunological studies demonstrated preserved neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent reactive oxygen species production, whereas bactericidal/permeability-increasing protein (BPI) was uniquely and markedly reduced among neutrophil antimicrobial proteins. In parallel, monocyte-derived dendritic cells exhibited impaired tumor necrosis factor-α (TNF-α) production in response to mycobacterial stimulation, suggesting impaired cytokine responses downstream of CARD9.
Conclusion: These findings suggest that impaired dendritic cell cytokine responses to mycobacteria, together with markedly reduced neutrophil BPI content, may have contributed to the development of M. intracellulare infection in this patient. Our study highlights a potential mechanism underlying susceptibility to mycobacterial infection in CARD9 deficiency.
期刊介绍:
Clinical & Experimental Immunology (established in 1966) is an authoritative international journal publishing high-quality research studies in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice.
The journal is focused on translational and clinical immunology and is among the foremost journals in this field, attracting high-quality papers from across the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through scientific studies to the treatment, prevention or diagnosis of human disease. Clinical immunology has evolved as a field to encompass the application of state-of-the-art technologies such as next-generation sequencing, metagenomics and high-dimensional phenotyping to understand mechanisms that govern the outcomes of clinical trials.